Jon T. Giles

11.3k total citations · 4 hit papers
154 papers, 6.6k citations indexed

About

Jon T. Giles is a scholar working on Rheumatology, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Jon T. Giles has authored 154 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Rheumatology, 38 papers in Cardiology and Cardiovascular Medicine and 25 papers in Immunology. Recurrent topics in Jon T. Giles's work include Rheumatoid Arthritis Research and Therapies (100 papers), Systemic Lupus Erythematosus Research (58 papers) and Viral Infections and Immunology Research (30 papers). Jon T. Giles is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (100 papers), Systemic Lupus Erythematosus Research (58 papers) and Viral Infections and Immunology Research (30 papers). Jon T. Giles collaborates with scholars based in United States, United Kingdom and Spain. Jon T. Giles's co-authors include Joan M. Bathon, Felipe Andrade, Antony Rosen, Erika Darrah, Robert Winchester, Kevin R. Fontaine, Susan J. Bartlett, Allan C. Gelber, Roger S. Blumenthal and Wendy S. Post and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Gastroenterology.

In The Last Decade

Jon T. Giles

149 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aggregatibacter actinomycetemcomitans –induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis

2016 426 citations Jeremy Sokolove, Jon T. Giles et al. profile →
Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions

2018 339 citations Jon T. Giles et al. profile →
Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance

2022 123 citations Christina Charles‐Schoeman, Maya H Buch et al. Annals of the Rheumatic Diseases profile →
Shared inflammatory pathways of rheumatoid arthritis and atherosclerotic cardiovascular disease

2023 75 citations Jon T. Giles, Katherine P. Liao et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jon T. Giles United States	45	3.6k	1.5k	1.1k	917	877	154	6.6k
Cristiano Alessandri Italy	47	3.1k 0.9×	1.9k 1.3×	468 0.4×	1.1k 1.2×	1.4k 1.5×	305	6.8k
Martin Soubrier France	42	3.5k 1.0×	1.1k 0.7×	500 0.5×	997 1.1×	656 0.7×	300	6.7k
Carl Turesson Sweden	45	4.6k 1.3×	1.2k 0.8×	516 0.5×	907 1.0×	574 0.7×	170	6.6k
Mauro Galeazzi Italy	49	3.8k 1.0×	1.9k 1.3×	672 0.6×	1.2k 1.3×	2.0k 2.3×	199	7.9k
Johan Rönnelid Sweden	46	5.3k 1.5×	2.7k 1.8×	420 0.4×	702 0.8×	926 1.1×	174	8.2k
Xiaofeng Zeng China	42	2.8k 0.8×	1.8k 1.2×	1.5k 1.4×	725 0.8×	1.4k 1.6×	488	9.2k
Gianfranco Ferraccioli Italy	59	6.0k 1.6×	2.7k 1.8×	486 0.5×	1.7k 1.9×	1.1k 1.3×	370	11.5k
Maria G. Tektonidou Greece	44	4.9k 1.3×	2.0k 1.3×	492 0.5×	1.5k 1.7×	600 0.7×	207	7.0k
Solbritt Rantapää‐Dahlqvist Sweden	61	8.4k 2.3×	3.7k 2.5×	1.2k 1.1×	1.5k 1.6×	1.6k 1.8×	248	12.6k
Florenzo Iannone Italy	42	3.3k 0.9×	1.4k 1.0×	215 0.2×	1.1k 1.2×	1.0k 1.2×	349	6.8k

Countries citing papers authored by Jon T. Giles

Since Specialization

Citations

This map shows the geographic impact of Jon T. Giles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon T. Giles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon T. Giles more than expected).

Fields of papers citing papers by Jon T. Giles

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon T. Giles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon T. Giles. The network helps show where Jon T. Giles may publish in the future.

Co-authorship network of co-authors of Jon T. Giles

This figure shows the co-authorship network connecting the top 25 collaborators of Jon T. Giles. A scholar is included among the top collaborators of Jon T. Giles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon T. Giles. Jon T. Giles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Parimon, Tanyalak, Edo Israely, Youn Jung Choi, et al.. (2026). Single‐Cell Analysis Reveals Peripheral Helper T Cells in Rheumatoid Arthritis–Related Interstitial Lung Disease. Arthritis & Rheumatology.

Charles‐Schoeman, Christina, Jon T. Giles, Nancy E. Lane, et al.. (2024). Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years. Rheumatology and Therapy. 11(1). 157–175. 5 indexed citations

Pappas, Dimitrios A., George Reed, Kevin Kane, et al.. (2024). Effect of biologic agents and inflammation on lipid levels and cardiovascular risk in rheumatoid arthritis patients. Seminars in Arthritis and Rheumatism. 68. 152504–152504. 1 indexed citations

Wang, Hong, Jon T. Giles, Alexander A. Girgis, et al.. (2024). The monocyte cell surface is a unique site of autoantigen generation in rheumatoid arthritis. Proceedings of the National Academy of Sciences. 121(17). e2304199121–e2304199121. 2 indexed citations

Solomon, Daniel H., Olga Demler, Pamela M. Rist, et al.. (2024). Biomarkers of Cardiovascular Risk in Patients With Rheumatoid Arthritis: Results From the TARGET Trial. Journal of the American Heart Association. 13(5). e032095–e032095. 1 indexed citations

Park, Elizabeth, Isabelle Amigues, Laura Geraldino‐Pardilla, et al.. (2024). Associations of galectin-3 levels with measures of vascular disease in patients with rheumatoid arthritis. Seminars in Arthritis and Rheumatism. 65. 152357–152357. 2 indexed citations

Giles, Jon T., Daniel H. Solomon, Katherine P. Liao, et al.. (2024). Association of the multi-biomarker disease activity score with arterial 18-fluorodeoxyglucose uptake in rheumatoid arthritis. Lara D. Veeken. 64(3). 1077–1083. 1 indexed citations

Reid, Pankti, David Liew, Alexander C. Peterson, et al.. (2023). JAK inhibitors and black box warnings: what is the future for JAK inhibitors?. Expert Review of Clinical Immunology. 19(11). 1385–1397. 11 indexed citations

Park, Elizabeth, Ito K, Isabelle Amigues, et al.. (2022). Prospective changes in diastolic function in patients with rheumatoid arthritis. Arthritis Research & Therapy. 24(1). 184–184. 3 indexed citations

10.

Charles‐Schoeman, Christina, et al.. (2022). OP0264 IMPACT OF BASELINE CARDIOVASCULAR RISK ON THE INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN THE TOFACITINIB RHEUMATOID ARTHRITIS CLINICAL PROGRAMME. Annals of the Rheumatic Diseases. 81. 175–176. 4 indexed citations

11.

Charles‐Schoeman, Christina, Maya H Buch, Deepak L. Bhatt, et al.. (2022). POS0674 RISK FACTORS FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS AGED ≥50 YEARS WITH RHEUMATOID ARTHRITIS AND ≥1 ADDITIONAL CARDIOVASCULAR RISK FACTOR: A POST HOC ANALYSIS OF ORAL SURVEILLANCE. Annals of the Rheumatic Diseases. 81. 611–612. 4 indexed citations

12.

Buch, Maya H, et al.. (2022). POS0237 MAJOR ADVERSE CARDIOVASCULAR EVENTS, MALIGNANCIES AND VENOUS THROMBOEMBOLISM BY BASELINE CARDIOVASCULAR RISK: A POST HOC ANALYSIS OF ORAL SURVEILLANCE. Annals of the Rheumatic Diseases. 81. 356–357. 8 indexed citations

13.

Park, Elizabeth, Jon T. Giles, Yevgeniya Gartshteyn, et al.. (2021). Hydroxychloroquine use is not associated with QTc length in a large cohort of SLE and RA patients. Arthritis Research & Therapy. 23(1). 271–271. 9 indexed citations

14.

Anderson, Michaela R., John S. Kim, Matthew Allison, et al.. (2021). Adiposity and Interstitial Lung Abnormalities in Community-Dwelling Adults. CHEST Journal. 160(2). 582–594. 15 indexed citations

15.

Faye, Adam S., Eunah Lee, Monika Laszkowska, et al.. (2020). Risk of Adverse Outcomes in Hospitalized Patients With Autoimmune Disease and COVID-19: A Matched Cohort Study From New York City. The Journal of Rheumatology. 48(3). 454–462. 21 indexed citations

16.

Hughes‐Austin, Jan M., Kevin D. Deane, Jon T. Giles, et al.. (2018). Plasma adiponectin levels are associated with circulating inflammatory cytokines in autoantibody positive first-degree relatives of rheumatoid arthritis patients. PLoS ONE. 13(6). e0199578–e0199578. 9 indexed citations

17.

Baker, Joshua F., Jon T. Giles, David R. Weber, et al.. (2017). Assessment of muscle mass relative to fat mass and associations with physical functioning in rheumatoid arthritis. Lara D. Veeken. 56(6). 981–988. 27 indexed citations

18.

Edwards, Robert R., Jon T. Giles, Clifton O. Bingham, et al.. (2010). Moderators of the Negative Effects of Catastrophizing in Arthritis. Pain Medicine. 11(4). 591–599. 31 indexed citations

19.

Giles, Jon T., Ashkan A. Malayeri, Verônica Fernandes, et al.. (2010). Left ventricular structure and function in patients with rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging. Arthritis & Rheumatism. 62(4). 940–951. 87 indexed citations

20.

Henry, N. Lynn, Jon T. Giles, & Vered Stearns. (2008). Aromatase inhibitor-associated musculoskeletal symptoms: etiology and strategies for management.. PubMed. 22(12). 1401–8. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact